Meaningful Innovation from Discovery to Translation

Join us for the Bridge Program’s final seminar for 2022, with a focus on meaningful innovation on the discovery-to-translation pathway.

This event is brought to you in association with University of Western Australia and MTPConnect, at the Harry Perkins Institute of Medical Research in WA. It’s also the perfect pre-Ausbiotech networking opportunity.

Program

The day will include:

• Keynote presentation from Anand Gautam (Pfizer)
• Roundtable discussion with Prof Lyn Griffiths (QUT), Jarrod Belcher (MTPConnect) and Anand Gautam
• Networking morning tea and lunch
• MTPConnect announcement from Jarrod Belcher
• Official close of the 2022 Bridge Program by Prof Lyn Griffiths
• You are also welcome to stay for the AusBiotech All Aboard WA Biotech Tour presentations in the afternoon.

Our keynote speaker

Anand Gautam, Pfizer

Anand Gautam is the Executive Director & Emerging Science Lead (Asia & Asia Pacific), Pfizer. Anand has over 25 years of R&D leadership experience in inflammation and autoimmune diseases with a focus on cancer. He has developed innovation strategies for international biotech and pharmaceutical companies, and has over 12 years of immunology research experience gained in prestigious research centres globally. Anand is excited about novel science and its potential for translation into medicine. His goal is to help convert meaningful scientific discoveries into real innovation, changing people’s lives with new medicine.

Who should attend?

This event is open to all.

Register

Details: